Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: Are the results reflected in observed toxicity rates?
Martin A Ebert, Max Bulsara, Annette Haworth, Rachel Kearvell, Sharon Richardson, Angel Kennedy, Nigel A Spry, Sean A Bydder, David J Joseph, James W Denham
Journal of Medical Imaging and Radiation Oncology | WILEY | Published : 2015
Awarded by Diagnostics and Technology Branch of the Australian Government Department of Health and Ageing
Awarded by National Health and Medical Research Council
We acknowledge funding from Cancer Australia and the Diagnostics and Technology Branch of the Australian Government Department of Health and Ageing (grant 501106), the National Health and Medical Research Council (grants 300705, 455521, 1006447), the Hunter Medical Research Institute, the Health Research Council (New Zealand), the University of Newcastle the Calvary Mater Newcastle, the Abbott Laboratories and the Novartis Pharmaceuticals. We gratefully acknowledge the support of the Sir Charles Gairdner Hospital, the 'Elvis' study team, the contour audit team, participating RADAR centres, Chantelle Wilcox, the Trans-Tasman Radiation Oncology Group, Jean Ball, Cate Sproston, Sean Hall, Celia Gordon, Scott Chandler, Scott Williams, Mahesh Kumar, Rhonda Coleman, David Lamb, Judy Murray, Ben Hooton and Elizabeth van der Wath.